Kura Oncology

Quarterly Financials

Values in thousands2025-09-302025-06-302025-03-312024-12-31
Revenue
$20,750
$15,288
$14,108
$53,883
Gross Profit
17,538
15,288
14,108
53,883
EBITDA
-73,952
-65,507
-64,700
-16,592
EBIT
-74,116
-65,731
-57,585
-16,796
Net Income
-74,116
-66,122
-57,429
-19,217
Net Change In Cash
20,750
15,288
14,108
53,883
Free Cash Flow
-83,193
-30,235
-72,219
268,759
Cash
95,287
81,948
51,269
224,462
Basic Shares
87,645
87,586
87,415
87,136

Annual Financials

Values in thousands2024-12-312023-12-312022-12-312021-12-31
Revenue
$53,883
$0
$0
$0
Gross Profit
53,883
-849
-759
-558
EBITDA
-169,498
-150,233
-134,852
-129,494
EBIT
-170,346
-151,082
-135,611
-130,052
Net Income
-173,983
-152,631
-135,840
-130,466
Net Change In Cash
53,883
0
0
0
Cost of Revenue
-38,870
-234,821
Free Cash Flow
133,845
-124,992
-110,688
-105,698
Cash
224,462
37,318
51,802
90,672
Basic Shares
86,161
73,229
66,990
66,352

Earnings Calls

QuarterEPS
2025-12-31
$0
2025-09-30
-$0.85
2025-06-30
-$0.75
2025-03-31
-$0.66